Strumento inattivo

Resoconti EnteroMedics Inc Nasdaq

Azioni

US29365M2089

Resoconti

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024	01/04
Transcript : ReShape Lifesciences Inc., Q3 2023 Earnings Call, Nov 08, 2023	08/11
Transcript : ReShape Lifesciences Inc., Q2 2023 Earnings Call, Aug 07, 2023	07/08/23
Transcript : ReShape Lifesciences Inc., Q1 2023 Earnings Call, May 15, 2023	15/05/23
Transcript : ReShape Lifesciences Inc., 2022 Earnings Call, Apr 25, 2023	25/04/23
ReShape Lifesciences Inc. Fornisce una guida alle entrate	14/11/22	CI
Transcript : ReShape Lifesciences Inc., Q3 2022 Earnings Call, Nov 14, 2022	14/11/22
Transcript : ReShape Lifesciences Inc., Q2 2022 Earnings Call, Aug 15, 2022	15/08/22
Transcript : ReShape Lifesciences Inc., Q1 2022 Earnings Call, May 23, 2022	23/05/22
Transcript : ReShape Lifesciences Inc., Q4 2021 Earnings Call, Mar 28, 2022	28/03/22
Transcript : ReShape Lifesciences Inc., Q3 2021 Earnings Call, Nov 11, 2021	11/11/21
Transcript : ReShape Lifesciences Inc., Q2 2021 Earnings Call, Aug 16, 2021	16/08/21
Transcript : Obalon Therapeutics, Inc. - Shareholder/Analyst Call	25/05/21
Transcript : ReShape Lifesciences Inc., Q1 2021 Earnings Call, May 18, 2021	18/05/21
Transcript : ReShape Lifesciences Inc., Q4 2020 Earnings Call, Mar 10, 2021	10/03/21
Transcript : ReShape Lifesciences Inc., Q3 2020 Earnings Call, Nov 12, 2020	12/11/20
Transcript : ReShape Lifesciences Inc., Q2 2020 Earnings Call, Aug 13, 2020	13/08/20
Transcript : ReShape Lifesciences Inc., Q4 2019 Earnings Call, Mar 26, 2020	26/03/20
Transcript : Obalon Therapeutics, Inc., Q4 2019 Earnings Call, Feb 27, 2020	27/02/20
Transcript : ReShape Lifesciences Inc., Q3 2019 Earnings Call, Nov 14, 2019	14/11/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Resoconti EnteroMedics Inc Nasdaq

Azioni

US29365M2089

Resoconti

Filtri